Molecular of specificity of 5-androstenediol as a systemic radioprotectant in mice

Immunopharmacology and Immunotoxicology

Volumn 27, Issue 1, 2005, Pages 15-32

  Whitnall, Mark H ^a   Villa, Vilmar ^a   Seed, Thomas M ^a   Benjack, James ^a   Miner, Venita ^a   Lewbart, Marvin L ^b   Dowding, Charles A ^c   Jackson III, William E ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b Custom Steroid Synthesis   (United States)

^c Hollis Eden Pharmaceuticals Inc   (United States)

Author keywords

5 Androstene 3 beta,7 beta,17 beta triol; Androst 5 ene 3 beta,17 beta diol; Natural immunity; Radiation protection; Steroids; Structure activity relationship

Indexed keywords

16ALPHA BROMOEPIANDROSTERONE; 16ALPHA FLUOROANDROST 5 EN 17ALPHA OL; 16ALPHA FLUOROANDROST 5 EN 17BETA OL; 17ALPHA ANDROSTENEDIOL; ANDROSTENEDIOL; ANDROSTENEDIONE; ESTRADIOL; FLUASTERONE; PRASTERONE; RADIOPROTECTIVE AGENT; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; FEMALE; GAMMA IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; STRUCTURE ACTIVITY RELATION;

EID: 15244359425     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1081/IPH-51289     Document Type: Article

References (61)

1. Madonna, G.S.; Ledney, G.D.; Elliott, T.B.; Brook, I.; Ulrich, J.T.; Myers, K.R.; Patchen, M.L.; Walker, R.I. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect. Immun. 1989, 57, 2495-2501.
2. Hendry, J.H.; Lord, B.I. Radiation Toxicology: Bone Marrow and Leukaemia; Taylor & Francis: London, 1995.
3. Moulder, J.E. Report on an interagency workshop on the radiobiology of nuclear terrorism. Molecular and cellular biology of moderate dose (1-10 Sv) radiation and potential mechanisms of radiation protection (Bethesda, MD, December 17-18, 2001). Radiat. Res. 2002, 158, 118-124.
4. Srinivasan, V.; Pendergrass, J.A., Jr.; Kumar, K.S.; Landauer, M.R.; Seed, T.M. Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets. Int. J. Radiat. Biol. 2002, 78, 535-543.
5. Mitchell, J.B.; Krishna, M.C. Nitroxides as radiation protectors. Mil. Med. 2002, 167, 49-50.
6. Kumar, K.S.; Srinivasan, V.; Toles, R.; Jobe, L.; Seed, T.M. Nutritional approaches to radioprotection: vitamin E. Mil. Med. 2002, 167, 57-59.
7. MacVittie, T.J.; Farese, A.M. Experimental approaches to treatment of radiation-induced hematopoietic injury. In Radiation Toxicology: Bone Marrow and Leukaemia; Hendry, J.H., Lord, B.I., Eds.; Taylor & Francis: London, 1995; 141-194.
8. Davison, B.; Large, D.M.; Anderson, D.C.; Robertson, W.R. Basal steroid production by the zona reticularis of the guinea-pig adrenal cortex. J. Steroid Biochem. 1983, 18, 285-290.
9. Berliner, D.L.; Pasqualini, J.R.; Gallegos, A.J. The formation of water soluble steroids by human skin. J. Invest. Dermatol. 1968, 50, 220-224.
10. Bird, C.E.; Morrow, L.; Fukumoto, Y.; Marcellus, S.; Clark, A.F. Delta5-androstenediol: kinetics of metabolism and binding to plasma proteins in normal men and women. J. Clin. Endocrinol. Metab. 1976, 43, 1317-1322.
11. Seki, M.; Kimura, T.; Takayama, T.; Yanaihara, T.; Nakayama, T. Biosynthesis of steroids by human fetal kidney perfused in vitro. Acta Obstet. Gynaecol. Jpn. 1981, 33, 805-812.
12. Schmidt, M.; Kreutz, M.; Loffler, G.; Scholmerich, J.; Straub, R.H. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J. Endocrinol. 2000, 164, 161-169.
13. Hernandez-Pando, R.; De La Luz Streber, M.; Orozco, H.; Arriaga, K.; Pavon, L.; Al-Nakhli, S.A.; Rook, G.A. The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology 1998, 95, 234-241.
14. Araghi-Niknam, M.; Liang, B.; Zhang, Z.; Ardestani, S.K.; Watson, R.R. Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by dehydroepiandrosterone sulphate (DHEAS). Immunology 1997, 90, 344-349.
15. Whitnall, M.H.; Elliott, T.B.; Harding, R.A.; Inal, C.E.; Landauer, M.R.; Wilhelmsen, C.L.; McKinney, L.; Miner, V.L.; Jackson, W.E., III; Loria, R.M.; Ledney, G.D.; Seed, T.M. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int. J. Immunopharmacol. 2000, 22, 1-14.
16. Whitnall, M.H.; Inal, C.E.; Jackson, W.E., III; Miner, V.L.; Villa, V.; Seed, T.M. In vivo radioprotection by 5-androstenediol: stimulation of the innate immune system. Radiat. Res. 2001, 156, 283-293.
17. Whitnall, M.H.; Wilhelmsen, C.L.; McKinney, L.; Miner, V.L.; Seed, T.M.; Jackson, W.E., III. Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol. Immunotoxicol. 2002, 24, 595-626.
18. Daigle, J.; Carr, D.J. Androstenediol antagonizes herpes simplex virus type 1-induced encephalitis through the augmentation of type I IFN production. J. Immunol. 1998, 160, 3060-3066.
19. Carr, D.J. Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J. Neuroimmunol. 1998, 89, 160-167.
20. Padgett, D.A.; Loria, R.M. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J. Neuroimmunol. 1998, 84, 61-68.
21. Morfin, R.; Courchay, G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J. Steroid Biochem. Mol. Biol. 1994, 50, 91-100.
22. Rasmussen, K.R.; Martin, E.G.; Healey, M.C. Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. J. Parasitol. 1993, 79, 364-370.
23. Araneo, B.; Daynes, R. Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology 1995, 136, 393-401.
24. Ben-Nathan, D.; Padgett, D.A.; Loria, R.M. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J. Med. Microbiol. 1999, 48, 425-431.
25. Loria, R.M.; Inge, T.H.; Cook, S.S.; Szakal, A.K.; Regelson, W. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J. Med. Virol. 1988, 26, 301-314.
26. Peters, J.M.; Zhou, Y.C.; Ram, P.A.; Lee, S.S.; Gonzalez, F.J.; Waxman, D.J. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Mol. Pharmacol. 1996, 50, 67-74.
27. Ripp, S.L.; Fitzpatrick, J.L.; Peters, J.M.; Prough, R.A. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Drug Metab. Dispos. 2002, 30, 570-575.
28. Miyamoto, H.; Yeh, S.; Lardy, H.; Messing, E.; Chang, C. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 11083-11088.
29. Poortman, J.; Prenen, J.A.; Schwarz, F.; Thijssen, J.H. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab. 1975, 40, 373-379.
30. Adams, J.; Garcia, M.; Rochefort, H. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res. 1981, 41, 4720-4726.
31. Baulieu, E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998, 23, 963-987.
32. Yeh, S.; Kang, H.Y.; Miyamoto, H.; Nishimura, K.; Chang, H.C.; Ting, H.J.; Rahman, M.; Lin, H.K.; Fujimoto, N.; Hu, Y.C.; Mizokami, A.; Huang, K.E.; Chang, C. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine 1999, 11, 195-202.
33. Javitt, N.B.; Lee, Y.C.; Shimizu, C.; Fuda, H.; Strott, C.A. Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology 2001, 142, 2978-2984.
34. Belanger, B.; Caron, S.; Belanger, A.; Dupont, A. Steroid fatty acid esters in adrenals and plasma: effects of ACTH. J. Endocrinol. 1990, 127, 505-511.
35. Le Goascogne, C.; Sananès, N.; Eychenne, B.; Gouézou, M.; Baulieu, E.-E.; Robel, P. Androgen biosynthesis in the stomach: expression of cytochrome P450 17α-hydroxylase/17,20-lyase messenger ribonucleic acid and protein, and metabolism of pregnenolone and progesterone by parietal cells of the rat gastric mucosa. Endocrinology 1996, 136, 1744-1752.
36. May, M.; Holmes, E.; Rogers, W.; Poth, M. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sci. 1990, 46, 1627-1631.
37. Padgett, D.A.; Sheridan, J.F. Androstenediol (AED) prevents neuroendocrine-mediated suppression of the immune response to an influenza viral infection. J. Neuroimmunol. 1999, 98, 121-129.
38. Loria, R.M.; Padgett, D.A.; Huynh, P.N. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J. Endocrinol. 1996, 150 Suppl, S209-S220.
39. Padgett, D.A.; Loria, R.M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol. 1994, 153, 1544-1552.
40. Huynh, P.N.; Carter, W.H., Jr.; Loria, R.M. 17 Alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell lines. Cancer Detect. Prev. 2000, 24, 435-444.
41. Sonka, J.; Strakova, M. Survival of irradiated mice pretreated by dehydroepiandrosterone. Agressologie 1970, 11, 421-426.
42. Inano, H.; Ishii-Ohba, H.; Suzuki, K.; Yamanouchi, H.; Onoda, M.; Wakabayashi, K. Chemoprevention by dietary dehydroepiandrosterone against promotion/progression phase of radiation-induced mammary tumorigenesis in rats. J. Steroid Biochem. Mol. Biol. 1995, 54, 47-53.
43. Loria, R.M.; Conrad, D.H.; Huff, T.; Carter, H.; Ben-Nathan, D. Androstenetriol and androstenediol. Protection against lethal radiation and restoration of immunity after radiation injury. Ann. N. Y. Acad. Sci. 2000, 917, 860-867.
44. Rugh, R.; Wolff, J. Relation of gonad hormones to x-irradiation sensitivity in mice. Proc. Soc. Exp. Biol. Med. 1956, 92, 408-410.
45. Hinterberger, W.; Vierhapper, H. Anabolic steroids and blood cell production. Wien Med. Wochenschr. 1993, 143, 380-382.
46. Gallicchio, V.S.; Chen, M.G.; Watts, T.D. The enhancement of committed hematopoietic stem cell colony formation by nandrolone decanoate after sublethal whole body irradiation. Int. J. Cell Cloning 1984, 2, 383-393.
47. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals; National Academy Press: Washington, DC, 1996.
48. Hammer, J.G.; Harris, H.A.; Komm, B.S.; Goodwin, T.; Goldberg, K.; Van Winkle, T. Comparison of gross and histologie effects of six vehicles for subcutaneous injection of hydrophobic steroid mimetic compounds in rats (abstract). Contem. Top. Lab. Anim. Sci. 1996, 35, 72.
49. Bartsch, W.; Sponer, G.; Dietmann, K.; Fuchs, G. Acute toxicity of various solvents in the mouse and rat. Arzneimittelforschung 1976, 26, 1581-1583.
50. Myska, J.C.; Adams, T.L.; Bhatt, R.C.; Broom, J.G.; Pitcher, C.D.; Sharpnack, F.M., II; St. John, T.J.; Torres, B.A.; Vavrina, G.; Gerstenberg, H.M. Arrays for Use at the Cobalt Irradiation Facility, AFRRI Technical Report 97-2; Armed Forces Radiobiology Research Institute: Bethesda, MD, 1997.
51. American Association of Physicists in Medicine (AAPM Task Group 21). A protocol for the determination of absorbed dose from high-energy photon and electron beams. Med. Phys. 1983, 10, 741-771.
52. Verjans, H.L.; Eik-Nes, K.B. Effects of androstenes, 5alpha-androstanes, 5beta-androstanes, oestrenes and oestratrienes on serum gonadotrophin levels and ventral prostate weights in gonadectomized, adult male rats. Acta Endocrinol. (Copenh.) 1976, 83, 201-210.
53. Begin, D.; Luthy, I.A.; Labrie, F. Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol. Cell. Endocrinol. 1988, 58, 213-219.
54. Coffey, D.S. Androgen action and the sex accessory tissues. In The Physiology of Reproduction; Knobil, E., Neill, J., Eds.; Raven Press: New York, 1988; 1081-1119.
55. Paris, F.; Servant, N.; Terouanne, B.; Sultan, C. Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results. Mol. Cell. Endocrinol. 2002, 198, 123-129.
56. Labrie, C.; Belanger, A.; Labrie, F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 1988, 123, 1412-1417.
57. Labrie, C.; Simard, J.; Zhao, H.F.; Belanger, A.; Pelletier, G.; Labrie, F. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 1989, 124, 2745-2754.
58. Schwartz, A.G.; Pashko, L.L. Inhibition of adjuvant-induced arthritis by 16 alpha-fluoro-5-androsten-17-one. Mil. Med. 2002, 167, 60-63.
59. Ayi, K.; Giribaldi, G.; Skorokhod, A.; Schwarzer, E.; Prendergast, P.T.; Arese, P. 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob. Agents Chemother. 2002, 46, 3180-3184.
60. VanderKuur, J.A.; Wiese, T.; Brooks, S.C. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry 1993, 32, 7002-7008.
61. Huynh, P.N.; Loria, R.M. Contrasting effects of alpha- and beta-androstenediol on oncogenic myeloid cell lines in vitro. J. Leukoc. Biol. 1997, 62, 258-267.